Table 3.
RS 1 | RS 2 | RS 3 | RS 4 | |
---|---|---|---|---|
Functional connectivitya | ||||
Placebo | 0.1257 ± 0.0141 | 0.1262 ± 0.0151 | 0.1365 ± 0.0163 | 0.1566 ± 0.0202 |
Nicotine | 0.1128 ± 0.0121 | 0.1155 ± 0.0213 | 0.1203 ± 0.0172 | 0.1153 ± 0.0159 |
Functional network topology and distance | ||||
Global efficiency | ||||
Placebo | 0.5512 ± 0.0006 | 0.5495 ± 0.0009 | 0.5487 ± 0.0010 | 0.5482 ± 0.0012 |
Nicotine | 0.5515 ± 0.0007 | 0.5504 ± 0.0012 | 0.5507 ± 0.0007 | 0.5500 ± 0.0009 |
Clustering | ||||
Placebo | 0.5636 ± 0.0078 | 0.5724 ± 0.0087 | 0.5799 ± 0.0089 | 0.5875 ± 0.0117 |
Nicotine | 0.5554 ± 0.0080 | 0.5583 ± 0.0124 | 0.5634 ± 0.0091 | 0.5646 ± 0.0102 |
Distance | ||||
Placebo | 68.07 ± 0.51 | 67.30 ± 0.74 | 66.47 ± 0.78 | 66.29 ± 0.6 |
Nicotine | 68.72 ± 0.42 | 67.66 ± 0.99 | 67.49 ± 0.56 | 67.12 ± 0.86 |
RS, Resting-state period.
a Wavelet scale 2; 0.08–0.17 Hz.